SKYE CIK: 1516551

Skye Bioscience, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.47
FY22:
−12.7
FY23:
−14.0
FY24:
−25.2
FY25:
−43.1
Change from FY21 to FY25
millions USD
FY21:
−0.09
FY22:
5.21
FY23:
6.60
FY24:
−0.25
FY25:
−19.5
Change from FY21 to FY25
millions USD
FY21:
13.1
FY22:
−0.21
FY23:
16.4
FY24:
83.6
FY25:
0.03
millions USD
FY21:
6.51
FY22:
−7.74
FY23:
9.09
FY24:
58.1
FY25:
−62.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.57
FY22:
−12.8
FY23:
−14.0
FY24:
−26.8
FY25:
−43.1

All amounts in millions USD Data source:SEC EDGAR